ReviewFrontiers in molecular biosciences2022

Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling.

Xia Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.